Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature

被引：0
|
作者：
Virginie Dufrost
Jessie Risse
Stéphane Zuily
Denis Wahl
机构：
[1] CHRU de Nancy,
[2] Vascular Medicine Division and Regional Competence Center For Rare Vascular And Systemic Autoimmune Diseases,undefined
[3] Inserm UMR_S 1116 at Lorraine University,undefined
来源：
Current Rheumatology Reports | 2016年 / 18卷
关键词：
Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Antiphospholipid antibodies; Thrombosis recurrence; Triple positivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
    Briana Williams
    Joseph J. Saseen
    Toby Trujillo
    Surabhi Palkimas
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 67 - 73
  • [32] Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
    Williams, Briana
    Saseen, Joseph J.
    Trujillo, Toby
    Palkimas, Surabhi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (01) : 67 - 73
  • [33] Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature
    Kajy, Marvin
    Shokr, Mohamed
    Ramappa, Preeti
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (06) : E584 - E590
  • [34] Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome
    Franco-Moreno, Anabel
    Izquierdo-Martinez, Aida
    Ancos-Aracil, Cristina
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04): : 213 - 219
  • [35] Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS)
    Benger, Matthew
    Vink, Jasper
    Snell, Luke Blagdon
    Breen, Karen
    BMJ CASE REPORTS, 2019, 12 (04)
  • [36] Antiphospholipid syndrome and direct oral anticoagulants: to the future and back again?
    Wahl, Denis
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (02) : 210 - 211
  • [37] Direct Oral Anticoagulants in Nephrotic Syndrome: Our Experience and Literature Review
    Nissar, Syed M.
    Kuchay, Abid A.
    Mir, Tajamul H.
    Goud, L. Naresh
    Latief, Muzamil
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (02) : 169 - 171
  • [38] Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study
    Malec, K.
    Broniatowska, E.
    Undas, A.
    LUPUS, 2020, 29 (01) : 37 - 44
  • [39] Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials
    Lee, Young H.
    Song, Gwan G.
    LUPUS, 2022, 31 (11) : 1335 - 1343
  • [40] Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
    Koval, Nazariy
    Alves, Mariana
    Placido, Rui
    Almeida, Ana G.
    Fonseca, Joao Eurico
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    Caldeira, Daniel
    RMD OPEN, 2021, 7 (02):
12345